| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |